Advertisement

Topics

Companies Related to "Global Development secures future drug candidate development CollegeHill" [Most Relevant Company Matches] - Page: 3 RSS

22:37 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Global Development secures future drug candidate development CollegeHill" found in our extensive corporate database of over 50,000 company records.

Showing "Global Development secures future drug candidate development CollegeHill" Companies 51–75 of 13,000+

Relevant

SuperGen

SuperGen's mission is to build a global, sustainable business by developing and commercializing new drug candidates for oncologists, hematologists, and their patients. Our company is comprised of many talented individuals who understand and can address the extraordinary challenges of drug development. Every day, each employee brings a unique perspective to his or her job. Some work alone, others a...


Curaxis Pharmaceutical Corp

Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. Curaxis' therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that...

Jennerex Biotherapeutics, Inc.

Jennerex Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of groundbreaking oncolytic immunotherapies for patients with life-threatening cancers. The company’s lead product candidate, Pexa-Vec (JX-594), is in mid-stage clinical development for the treatment of advanced primary liver cancer, ...


Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceuticals) technology. LEAP combines the power of biological selection with the advantages of medicinal chemistry in a unique molecular evolution process. PRAECIS employed LEAP in the development of PLENA...

S*BIO Pte Ltd

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug ...

Aptuit (Allendale) Inc

Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators. The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment...

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is a specialty pharmaceuticals company with an experienced team of experts in drug development focusing its efforts on the clinical development of new therapies for dyslipidemia. The lead product candidate is Epanova™, an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic ...

NAEJA-RGM Pharmaceuticals Inc.

NAEJA-RGM Pharmaceuticals Inc. is a global, early-stage drug discovery company with a promising new antibiotic project currently in preclinical development. NAEJA-RGM has other projects in various stages of development as well as a compound library developed over many years by Dr. Ronald G. Micetich’s drug discovery team. The headquarters and laborato...

Advinus Therapeutics

Advinus Therapeutics is a research-based Pharmaceutical Company founded by leading global pharmaceutical executives and promoted by the TATA Group. The company is the first of its kind in India to offer end-to-end development services to the global Pharma, Agro and Biotech industries and at the same time creating long-term value through internal and collab...

Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals, Inc. (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib® platform and is in the process of selecting a lead clinical ...

Spirita Oncology, LLC

Spirita Oncology is an integrated oncology research and development company with experience in developing, managing and optimizing global pharmaceutical drug development programs from late discovery, translational research and clinical development through market authorization and post-marketing life-cycle management.

DOV Pharmaceutical, Inc

DOV Pharmaceutical, Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, or CNS, disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression.DOV currently has three product candidates in various stages of clinica...

Medicine & Business Kft

Medicine & Business is an ambitious, dynamic organization with a comprehensive knowledge of the health care environment in Hungary. Medicine & Business is offering a mutually advantageous long-term partnership and assistance to develop a prosperous business which meets the consumer needs and thus secures growth via appropriate strategies and actions in a cost-effective way. Commitment to our partn...

Gentium S.p.A.

Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the development and manufacture of drugs to treat and prevent a variety of diseases and conditions, including vascular diseases related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan ...

Napo Pharmaceuticals, Inc.

Napo Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company based in South San Francisco, California. Founded in November 2001, Napo is developing a late-stage drug candidate, crofelemer, for gastrointestinal indications including chronic diarrhea in persons living with HIV/AIDS. Additionally, Napo has entered into a licensing agreement for the worldwide development and commerc...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...

Solace Pharmaceuticals

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin (BH4) pathway. ...

Pacific BioDevelopment, LLC.

Our mission at Pacific BioDevelopment is to provide the highest quality integrated drug development strategies in order to facilitate timely and cost efficient proof-of-concept results, entry into the clinic, or market approval. Our goal is to develop long term relationships with each client by providing comprehensive drug development strategies designed to accelerate time to approval. Since 1997,...

The Institute for Bioanalytics

IBA is a privately held biotechnology company whose mission is the delivery of customized bioanalytical method development and sample analysis services to its global client base. IBA can enhance the discovery and development of new drug targets through its expertise in biotechnology, proteomics, biomarker development, and multiplexing technology. Our objective is to develop and maintain long-term ...

ViroDefense INC

ViroDefense Inc is an antiviral research, development and consulting company that advocates for and facilitates development of effective antiviral pharmaceuticals that address global public health threats. ViroDefense Inc is presently focused on development of antiviral drugs for poliomyelitis. Currently, there are no poliovirus antiviral drug products available. ViroDefense INC has offices in...

Worldwide Clinical Trials

Accelerate Your Development Program with Pinpoint Therapeutic Focus and Complete Spectrum of Services Worldwide Clinical Trials is a global CRO that provides full-service drug development services to the pharmaceutical and biotechnology industries.   As one of the most innovative and scientifically-driven contract research organizations, we offer exceptionally strong clinical trial m...

Oncology Services India

Oncology Services (OS) is a leading internationally operating CRO with unmatched expertise and extensive experience in oncology drug development and study management. OS provides end to end solutions for drug development including services of Phase I to IV, regulatory affairs, consulting for drug development, medical writing, Data management and statistics, Quality assurance and pharmacovigilance.

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis Discovery focus on the development of solutions to support the global pharmaceutical industry to gain efficiency in their drug discovery programs.The name of the company is based on a constellation c...

Global Alliance for TB Drug Development

Omnio Healer AB

Omnio Healer AB is a pioneer company developing novel drug candidates based on a series of conceptual breakthroughs in inflammation research. This new, pro-inflammatory approach opens up completely new therapeutic strategies for wound healing and anti-infection. The company's lead drug candidate, aimed primarily at otological indications, has achieved very promising preclinical results and wil...


More From BioPortfolio on "Global Development secures future drug candidate development CollegeHill"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks